| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.45 | 5e-17 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |